Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde W Yancy

Showing results (21-30 of 644) with videos related to

Pageof 65
Sort By:
Journal of the American College of Cardiology|July 12, 2008
Vasodilator therapy for decompensated heart failureClyde W Yancy
Medgenmed : Medscape General Medicine|April 17, 2007
Executive summary of the African-American InitiativeClyde W Yancy
JAMA Cardiology|June 14, 2018
Addressing Cardiovascular Disease Disparities-Are We Getting Closer to the Truth?Clyde W Yancy
Reviews in Cardiovascular Medicine|September 7, 2006
Current approaches to monitoring and management of heart failureClyde W Yancy
Journal of the American College of Cardiology|August 9, 2014
In search of a solution from the STICH trialClyde W Yancy
JAMA|August 5, 2020
Academic Medicine and Black Lives Matter: Time for Deep ListeningClyde W Yancy
Ethnicity & Disease|November 20, 2012
Cardiovascular disease outcomes: priorities today, priorities tomorrow for research and community healthClyde W Yancy
Circulation|July 14, 2025
Health Equity: Are We There Yet?Clyde W Yancy
JAMA Cardiology|September 15, 2021
An Expanded Heart Failure Indication for Sacubitril/Valsartan: Evolving the Evidence BarClyde W Yancy
The Medical Clinics of North America|August 28, 2004
The prevention of heart failure in minority communities and discrepancies in health care delivery systemsClyde W Yancy
Pageof 65

Showing results (21-30 of 644) with videos related to

Sort By:
Pageof 65
Journal of the American College of Cardiology|July 12, 2008
Vasodilator therapy for decompensated heart failureClyde W Yancy
Medgenmed : Medscape General Medicine|April 17, 2007
Executive summary of the African-American InitiativeClyde W Yancy
JAMA Cardiology|June 14, 2018
Addressing Cardiovascular Disease Disparities-Are We Getting Closer to the Truth?Clyde W Yancy
Reviews in Cardiovascular Medicine|September 7, 2006
Current approaches to monitoring and management of heart failureClyde W Yancy
Journal of the American College of Cardiology|August 9, 2014
In search of a solution from the STICH trialClyde W Yancy
JAMA|August 5, 2020
Academic Medicine and Black Lives Matter: Time for Deep ListeningClyde W Yancy
Ethnicity & Disease|November 20, 2012
Cardiovascular disease outcomes: priorities today, priorities tomorrow for research and community healthClyde W Yancy
Circulation|July 14, 2025
Health Equity: Are We There Yet?Clyde W Yancy
JAMA Cardiology|September 15, 2021
An Expanded Heart Failure Indication for Sacubitril/Valsartan: Evolving the Evidence BarClyde W Yancy
The Medical Clinics of North America|August 28, 2004
The prevention of heart failure in minority communities and discrepancies in health care delivery systemsClyde W Yancy
Pageof 65